Doxorubicin pathways: pharmacodynamics and adverse effects by Thorn Caroline F, Oshiro Connie, Marsh Sharon, Hernandez-Boussard Tina, McLeod Howard, Klein Teri E, Altman Russ B in Pharmacogenetics and genomics (2010). PubMed

Abstract

Not available.

Discussed In Paper

Pathways

  1. Representation of the candidate genes involved in the action of doxorubicin in a stylized cancer cell.

  2. Representation of the candidate genes involved in adverse effects of doxorubicin in a stylized cardiomyocyte.

  3. Diagrammatic representation of the transport and metabolism of doxorubicin.